How much protection do you have after a single dose of Pfizer, AstraZeneca, Moderna or J&J?

According to Business Insider, Great Britain is pushing the second dose for up to 12 weeks in order to vaccinate people with the first dose as soon as possible. In the US, Centres for Disease Control and Prevention (CDC) recommended giving a second dose of Pfizer vaccine 21 days after the first dosage and 28 days after the first dose for Modernna, with an interval of up to six weeks in inevitable situations.

Data from a study of some 375,000 people in Great Britain found that both Pfizer and AstraZeneca vaccines reduced the coronary infection by 72 percent. The study says protection from a single dose is likely to last for at least 10 weeks, given the levels of antibodies measurement.

Second Dosage Delay Strategy

The authors of the study claim that the data supports the British strategy of delaying the second dose, but that people should get a second dose. Protection against Pfizer vaccine increased 90 percent after two doses. There is not yet enough data to make any conclusions about AstraZeneca.

Another study by Scotland, published in Lancet on April 23rd, found that a single dose of Pfizer vaccine was 91 percent effective against hospitalization from 28th to 34th after the vaccine. While a single dose of AstraZeneca was 88 percent effective after the same period of time, the study showed.

A study by England, published April 28, revealed that a single dose of Pfizer vaccine, or AstraZeneca, reduced COVID symptoms to up to 50 percent.

The record of how well vaccines work after a single dose are not always clear depends on what you measure and measure.

Stephen Evans, a professor of medical statistics and a former member of the European Trade Agency Bars Safety Commission, explained the data on Business Institute.

Evans said the best data from the American Food and Bars Administration (FDA) is from the late stages of testing each vaccine.

In the rest of the text, you can read the protection of just one dose of each vaccine based on this data.

Pfizer - B NTech protects at least 80 percent

After vaccinated with Pfizer, defense against COVID was 52.4 percent effective in protecting between the first and second doses, according to FDA documents. But the figure 52.4 percent includes 11 days before the start of the defence after the first dose, so the current percentage could be higher. The real value stands between 29.5 percent and 84.5 percent, according to the FDA.

Pfizer vaccine was 100 percent effective in protecting against hospital and death. This, however, was based on a small number: only four people in the experiment developed heavy COVID after receiving a placebo rather than a vaccine.

Modern Protection Is at least 80 percent

The Modern vaccine was 69.5 percent effective in preventing COVID with symptoms between the first and the second dosage, with a true value of between 43.5 and 84.5. The 69.5 per cent figure includes 13 days before the start of the defence, so the current percentage could be higher.

It is unclear how well a dose protects from hospital and death, since not many people have heavy COVIDs, two in the vaccinated group, and four in the placebo group.

Evans said in case of vaccine against COVID-19 of the symptoms, you get at least 80 percent protection, and perhaps more than 90 percent, after just one dose over 28 days. After 28 days, there is no knowing what protection is because it is not tested.

AstraZeneca protects more than 70 percent

Evans said it is more difficult to determine the exact number in the case of AstraZeneca vaccine, as different design studies were used in experiments at a later stage, and a major American research is under way. The FDA has not yet presented data on this vaccine in the same way that others do.

Based on reading existing studies, Evans said the effectiveness of a single dose of AstraZeneca vaccine would likely be at least 70 percent against COVIED with symptoms during the first 90 days. After that time period, it is not clear how much protection there is.

Johnson & Johnson defends 66 percent

In the evidence, J&J was involved in protecting moderate and heavy COVIDs rather than symptomsy COVIDs, such as Pfizer, Modernna and AstraZeneca.

The defence began after 14 days and was 66.1 percent effective after 28 days. The effect of the vaccine changed depending on where it was used. It was 72 percent effective in the United States, 64 percent in South Africa, and 68 percent in Brazil. Coronervirus varieties were being circulated in both countries that could partially avoid antibodies.

What does percentage efficiency mean?

The efficiency of the vaccine rate refers to the percentage of people who receive full protection after the vaccine. With 80 percent efficiency, 80 percent of people have full protection, and 20 have no protection. For those who receive full protection for the first time, a second dose improves the quality of the immune and its response to endurance.

In the case of people who fail to gain full protection after the first dose, some will receive full protection after the second dose. Some people will never develop full protection after vaculation, for their immune system does not respond at all, writes Business Insiver.